Hexamerization-enhanced CD37 and CD20 antibodies synergize in CDC to kill patient-derived CLL cells with unprecedented potency

Author(s):: Taylor, R.; Lindorfer, M.; Oostindie, S.; Cook, E.; Zent, C.; Burack, R.; Beurskens, F.; Schuurman, J.; Breij, E.; Parren, P.

Published: 2018
Publication type: Other

ImmunotherapyCancerFluorescence microscopyCD 20 and CD37 monoclonal antibodies

Date issued: 2018-10-01
Language: English
Publisher: PERGAMON-ELSEVIER SCIENCE LTD
hdl: 1887/121523
doi: 10.1016/j.molimm.2018.06.222